V

Serial Number 98876017
641

Registration Progress

Application Filed
Nov 27, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
98876017
Deadline
August 27, 2025
Description
Respond to Non-Final Office Action
Filing Date
November 27, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
641
Status Date
May 27, 2025
Application
Pending
Classes
005

Rights Holder

ONO PHARMACEUTICAL CO., LTD.

03
Address
1-5, Doshomachi 2-chome, Chuo-ku,
Osaka-shi, Osaka 541-8526
JP

Ownership History

ONO PHARMACEUTICAL CO., LTD.

Original Applicant
03
Osaka-shi, Osaka JP

Legal Representation

Attorney
Perla M. Kuhn
USPTO Deadlines 2 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OFFICE ACTION
Non-Final Action Mailed
CNRTR Aug 27, 2025 51 days Critical Until Nov 27, 2025
OFFICE ACTION
Non-Final Action E-Mailed
GNRTF Aug 27, 2025 51 days Critical Until Nov 27, 2025
Next deadline: Non-Final Action Mailed on August 27, 2025 (51 days)

Application History

7 events
Date Code Type Description
May 27, 2025 GNRT F NON-FINAL ACTION E-MAILED
May 27, 2025 CNRT R NON-FINAL ACTION WRITTEN
May 27, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2025 DOCK D ASSIGNED TO EXAMINER
May 14, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 27, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis.

Active Deadlines

Non-Final Action Mailed
Due: Aug 27, 2025
Non-Final Action E-Mailed
Due: Aug 27, 2025

Additional Information

Design Mark
The mark consists of the stylized letter "V". inside there is a stylized circle design in the color green and a blotch behind the overall design in the color blue; the color white represents background and it is not part of the mark.
Color Claim
The color(s) gold, green, and blue is/are claimed as a feature of the mark.

Classification

International Classes
005